drug
olodaterol hydrochloride
Marketedupdated 5mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
indications
investigational
COPD
all catalysts(0)
nothing on the calendar yet
Trials studying olodaterol hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 19, 2027
108 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Jan 19, 2027compositionUS 7727984108d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that